Search clinical trials for: Glucagon like peptide 1 receptor agonist
Total 1400 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, India, Taiwan, Poland, Australia, Estonia, Hungary, Germany, Slovakia, Canada, Croatia, Bulgaria, Puerto Rico, Czechia, Slovenia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2India
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
University of AarhusCompletedMyocardial Infarction | Stroke | Type 2 DiabetesDenmark
-
Novo Nordisk A/SNot yet recruitingObesityUnited Kingdom, Germany, Canada, United States, France
-
Eli Lilly and CompanyRecruitingDiabetes Mellitus, Type 2United States, Canada, Mexico, Argentina, Puerto Rico
-
Novo Nordisk A/SRecruiting
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Malaysia, Spain, United Kingdom, Thailand, India, Turkey, Mexico, Canada, Bulgaria, Argentina, Germany, France, Poland, South Africa, Brazil, Colombia, Denmark, Ireland, Japan
-
Novo Nordisk A/SActive, not recruitingEarly Alzheimer´s DiseaseCanada, United States, Taiwan, Netherlands, United Kingdom, Spain, Austria, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, China, Poland, Denmark, Czechia, Ireland, Japan, South Africa, Romania, S... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United States, India, Czechia, Canada, Latvia, United Kingdom, Portugal, Serbia, Poland, Romania, Brazil, Russian Federation, Slovakia, Bulgaria, Mexico, Germany, Greece, Israel
-
Vanderbilt University Medical CenterNashville VA Medical CenterActive, not recruitingChronic Kidney DiseasesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Denmark, Sweden, Austria
-
Mayo ClinicAstellas Pharma US, Inc.; University of Nebraska; Lantheus Medical ImagingCompletedCoronary Artery Disease | Diabetes Mellitus Type 2United States
-
Uppsala UniversityKarolinska Institutet; University of CopenhagenCompletedPhysiology | Gastroenterology | EndocrinologySweden
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Serbia, Italy, China, Poland, Hungary, Saudi Arabia
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseUnited States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Slovakia, Hungary, Brazil
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, China, Japan, Argentina, Puerto Rico, Mexico
-
Novo Nordisk A/SCompletedObesityUnited States, Spain, Australia, Hungary, United Kingdom, Netherlands, Canada, Argentina, Czechia, Germany, Denmark, Israel, Poland
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2India
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2 | Peripheral Arterial DiseaseSpain, Taiwan, China, India, United States, Canada, Thailand, Austria, Malaysia, Germany, Poland, Japan, Czechia, Greece, Belgium, Denmark, Hungary, Latvia, Norway, Sweden
-
Eli Lilly and CompanyCompletedHypoglycemia | Diabetes Mellitus, Type 1Germany
-
Chinese PLA General HospitalCompletedCoronary Angiography | Glucagon-like Peptide-1
-
Zealand PharmaCompleted
-
Hvidovre University HospitalCompleted
-
Johns Hopkins UniversitySociety of Critical Care MedicineTerminatedHypoglycemia | Critically IllUnited States
-
Shenzhen Institute of Advanced Technology, Chinese...Recruiting
-
Veru Inc.RecruitingObesity | Muscle LossUnited States
-
Loma Linda UniversityNovo Nordisk A/SRecruitingObesity | Weight Loss | Overweight or Obesity | Weight, Body | Obesity; Drug | Weight Loss TrajectoryUnited States
-
Novo Nordisk A/SActive, not recruitingEarly Alzheimer's DiseaseCanada, United States, Spain, Netherlands, United Kingdom, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, Poland, Denmark, Czechia, Ireland, Norway, Japan, Romania, South Africa, Sweden, Mexico, F... and more
-
Novo Nordisk A/SCompletedNon-alcoholic SteatohepatitisUnited States, Spain, France, United Kingdom, Germany
-
AdociaCompleted
-
Second Xiangya Hospital of Central South UniversityRecruitingFibrosis | Scleroderma, Systemic | SemaglutideChina
-
Novo Nordisk A/SRecruitingObesity or OverweightTaiwan, Japan
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United Kingdom, United States, Australia, India, Canada, Turkey, Netherlands, Italy, Poland, China, Germany, Malaysia, Israel, Hungary, Ukraine, Japan, South Africa, Russian Federation, Brazil, France, Bulgaria, Belgium, Thailand, Gree... and more
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
SanofiCompleted
-
University Hospital, Gentofte, CopenhagenCompletedType 1 Diabetes | Type 2 DiabetesDenmark
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2Germany
-
Yale UniversityCompletedObesity, Childhood | Neural DevelopmentUnited States
-
Vanderbilt University Medical CenterRecruitingType 1 DiabetesUnited States
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Malaysia, United Kingdom, Australia, Netherlands, Portugal, Austria, Israel, India, Greece, Lebanon, Mexico, New Zealand, North Macedonia, Puerto Rico, Romania, Russian Federation, Ukraine, Morocco, Belgium, Czechia, Taiw...
-
Novo Nordisk A/SCompletedHealthy ParticipantsUnited States, Canada
-
Boehringer IngelheimNot yet recruiting
-
State University of New York at BuffaloNational Center for Advancing Translational Sciences (NCATS)Active, not recruiting
-
Novo Nordisk A/SCompleted
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo...Not yet recruitingObesity | Diabetes type1United States
-
Capital Medical UniversityNot yet recruitingIdiopathic Intracranial Hypertension
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan